Highlights

Australia recognises India's Covaxin for travellers
Australia has already approved Covishield
Australia has opened its borders after nearly 20 months

Latest news

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Arun Govil returns to ‘Ramayana’ as King Dashrath in new poster

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

AAP stages ‘vote theft’ protest in Delhi, workers stopped by police barricades

Bharat Biotech's Covaxin gets Australia's formal nod for travellers

Name: Bharat Biotech's Covaxin gets Australia's formal nod for travellers
Uploaded: 2021-11-01T15:04:37.000+05:30
Duration: T00M46S
Channel: Editorji News Desk
Description: Australia's medicines and medical devices regulator on Monday formally recognised India’s Covid-19 vaccine Covaxin as the country's border was reopened for the first time in nearly 20 months. This recognition i...

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin.

Updated: Sep 02, 2022 10:53

Editorji News Desk

Join our WhatsApp Channel

Bharat Biotech's Covaxin gets Australia's formal nod for travellers

Australia's medicines and medical devices regulator on Monday formally recognised India’s Covid-19 vaccine Covaxin as the country's border was reopened for the first time in nearly 20 months.

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin.

Hyderabad-based Bharat Biotech's Covaxin, and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.

Also watch: Nod to Covaxin delayed further as WHO has more questions for Bharat Biotech

Australia has already recognised Covishield.

Australia's approval for Covaxin comes at a time when an expert panel of WHO is considering the vaccine-maker's application for emergency use authorisation.